Sanofi India board to review Q3 results, consider interim dividend

Sanofi India Limited announced that its board of directors will convene on Wednesday, October 29, 2025, to review and approve the unaudited financial statements for the quarter and nine-month period ending September 30, 2025. The board will also consider and potentially declare an interim dividend for the year 2025.

Sanofi India will host an investor/analyst call on the same day, October 29, 2025, from 4:30 p.m. to 5:30 p.m. IST, to discuss the unaudited financial results. Pre-registration for the call is required and will remain open until 12 p.m. IST on October 29, 2025, allowing participants to view the presentation and engage with company management.

The trading window for Sanofi India shares closed on Wednesday, October 1, 2025, and will remain closed until Friday, October 31, 2025 (inclusive), coinciding with the financial results publication. This closure is in accordance with the company's prior stock exchange intimation regarding trading window regulations.